Page last updated: 2024-08-22

3-hydroxyephedrine and Idiopathic Parkinson Disease

3-hydroxyephedrine has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bohnen, NI; Frey, KA; Gilman, S; Koeppe, RA; Raffel, DM; Wong, KK1
Berding, G; Dengler, R; Knapp, WH; Kolbe, H; Meyer, GJ; Peschel, T; Schrader, CH; van den Hoff, J1

Trials

1 trial(s) available for 3-hydroxyephedrine and Idiopathic Parkinson Disease

ArticleYear
[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:1

    Topics: Carbon Radioisotopes; Diagnosis, Differential; Ephedrine; Feasibility Studies; Heart; Humans; Liver; Metabolic Clearance Rate; Multiple System Atrophy; Myocardium; Organ Specificity; Parkinson Disease; Pilot Projects; Radiopharmaceuticals; Tomography, Emission-Computed; Vagus Nerve

2003

Other Studies

1 other study(ies) available for 3-hydroxyephedrine and Idiopathic Parkinson Disease

ArticleYear
Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET.
    Radiology, 2012, Volume: 265, Issue:1

    Topics: Aged; Carbon Radioisotopes; Case-Control Studies; Contrast Media; Ephedrine; Female; Heart; Heart Conduction System; Heart Ventricles; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Prospective Studies; Sympathetic Nervous System

2012